台湾急性甲型肝炎暴发期间HIV阳性患者对两种灭活甲型肝炎病毒疫苗组合的血清学应答相当
在台湾急性甲型肝炎暴发期间,这项16个月回顾性研究评估了HIV阳性个体对Havrix和Vaqta两种灭活甲肝疫苗两剂组合的血清学应答。Havrix-Vaqta组与Vaqta-Vaqta组在28-36周和48周的血清转化率相当,提示不同甲肝疫苗组合可互换;首剂Vaqta后血清转化率显著高于首剂Havrix(53.0% vs 32.4%)。
要点
- Havrix-Vaqta组与Vaqta-Vaqta组第28-36周血清转化率分别为82.3%和80.9%。
- 两组第48周血清转化率分别为94.7%和94.4%,提示不同甲肝疫苗组合可互换。
- 首剂Vaqta后血清转化率显著高于首剂Havrix(53.0% vs 32.4%)。
核心结论
- Havrix-Vaqta与Vaqta-Vaqta两种组合在HIV阳性个体中第28-36周和第48周的血清转化率相当,提示不同甲肝疫苗组合可互换。
研究设计与样本
- 这项16个月回顾性研究在台湾急性甲型肝炎暴发期间纳入HIV阳性个体,一组接种1剂Havrix后接种1剂Vaqta,另一组接种2剂Vaqta。
主要发现
- Havrix-Vaqta组与Vaqta-Vaqta组第28-36周血清转化率分别为82.3%和80.9%,绝对差1.3%(95%CI:-6.3%-3.7%)。
- Havrix-Vaqta组与Vaqta-Vaqta组第48周血清转化率分别为94.7%和94.4%,绝对差0.3%(95%CI:-2.6%-3.2%)。
- 首剂Vaqta后血清转化率为53.0%,显著高于首剂Havrix后的32.4%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We evaluated the serologic responses to different 2-dose combinations of the inactivated hepatitis A virus (HAV) vaccines Havrix and Vaqta among human immunodeficiency virus-positive individuals during an acute hepatitis A outbreak in Taiwan. In this 16-month retrospective study, one group received 1 dose of Havrix followed by 1 dose of Vaqta, and another group received 2 doses of Vaqta. The Havrix-Vaqta and Vaqta-Vaqta groups achieved similar seroconversion rates at weeks 28-36 (82.3% and 80.9%, respectively; absolute difference, 1.3% [95% confidence interval {CI}, -6.3%-3.7%]) and week 48 (94.7% and 94.4%, respectively; absolute difference, 0.3% [95% CI, -2.6%-3.2%]), suggesting the interchangeability of different combinations of HAV vaccines. The significantly higher seroconversion rate after the first dose of Vaqta, compared with the dose of Havrix (53.0% vs 32.4%) may provide potential benefits in preventing HAV infection during the outbreak.
引用
- Lin KY, Hsieh SM, Sheng WH, et al. Comparable Serologic Responses to 2 Different Combinations of Inactivated Hepatitis A Virus Vaccines in HIV-Positive Patients During an Acute Hepatitis A Outbreak in Taiwan. J Infect Dis. 2018. PMID: 29668951. doi:10.1093/infdis/jiy224
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。